TipRanks
Benitec Biopharma Ltd (BNTC)
NASDAQ:BNTC
US Market
BNTC
Benitec Biopharma
RESEARCH TOOLSreports
Want to see BNTC full AI Analyst Report?

Benitec Biopharma (BNTC) Stock News & Sentiment

316 Followers
BNTC: BB-301 Clinical Progress and Strong Cash Position Drive Ritu Baral’s Buy Rating
Premium
Ratings
BNTC: BB-301 Clinical Progress and Strong Cash Position Drive Ritu Baral’s Buy Rating
18d ago
BNTC
Benitec Biopharma Announces Board Changes and New Director
Premium
Company Announcements
Benitec Biopharma Announces Board Changes and New Director
4M ago
8K
BNTC
Benitec Biopharma: Buy Rating Reiterated on Promising BB-301 Data and Solid Cash Runway; $32 Price Target Maintained
Premium
Ratings
Benitec Biopharma: Buy Rating Reiterated on Promising BB-301 Data and Solid Cash Runway; $32 Price Target Maintained
4M ago
BNTC
Benitec Biopharma Reaffirmed at Buy on Strong Cash Runway and Clear BB-301 Pivotal Path in OPMD Dysphagia
Premium
Ratings
Benitec Biopharma Reaffirmed at Buy on Strong Cash Runway and Clear BB-301 Pivotal Path in OPMD Dysphagia
5M ago
BNTC
Reiterating Buy on Benitec: Promising Early BB-301 Data in OPMD Underpin $32 12‑Month Target
Premium
Ratings
Reiterating Buy on Benitec: Promising Early BB-301 Data in OPMD Underpin $32 12‑Month Target
7M ago
BNTC
Benitec Biopharma: Emerging BB-301 Clinical Profile and Upcoming Data Catalyst Support Buy Rating and $32 Target
Premium
Ratings
Benitec Biopharma: Emerging BB-301 Clinical Profile and Upcoming Data Catalyst Support Buy Rating and $32 Target
7M ago
BNTC
Benitec Biopharma Concludes 2025 Annual Stockholders Meeting
Premium
Company Announcements
Benitec Biopharma Concludes 2025 Annual Stockholders Meeting
10M ago
8K
BNTC
More BNTC News >

BNTC News on the Web

BNTC: BB-301 Clinical Progress and Strong Cash Position Drive Ritu Baral’s Buy Rating
TipRanks News
Bullish
Benitec Biopharma price target raised to $17 from $16 at Wedbush
TipRanks News
Bullish
Benitec Biopharma downgraded to Neutral from Buy at Guggenheim
TipRanks News
Neutral
Benitec Biopharma Announces Board Changes and New Director
TipRanks News
Bearish
Benitec Biopharma: Buy Rating Reiterated on Promising BB-301 Data and Solid Cash Runway; $32 Price Target Maintained
TipRanks News
Bullish
Leerink Partners Keeps Their Buy Rating on Benitec Biopharma (BNTC)
TipRanks News
Bullish
Benitec Biopharma Reaffirmed at Buy on Strong Cash Runway and Clear BB-301 Pivotal Path in OPMD Dysphagia
TipRanks News
Bullish
Is Benitec Biopharma (BNTC) Fairly Valued After Q3 FY2026 Earnings? EPS -0.24 vs est. -0. ...
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
BNTC
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BNTC’s Media Buzz Sentiment?
1 articles about BNTC were published this week. In an average week, 1.75 articles are published.
    What is BNTC’s weekly average amount of articles?
    In an average week, 1.75 articles about BNTC are published.
      What is BNTC’s News Sentiment?
      100% of articles about BNTC were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        RHHBYRoche Holding
        BAYRYBayer
        SNYSanofi
        CICigna
        TFXTeleflex
        Showing the stocks with the most bullish news sentiment over the past week